Welcome to our dedicated page for Keurig Dr Pepper SEC filings (Ticker: KDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Keurig Dr Pepper Inc. (NASDAQ: KDP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8‑K and other key documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts insight into material events, financing arrangements, leadership changes and transaction details affecting the beverage and coffee business.
Recent Form 8‑K filings describe several important developments. KDP has reported the declaration of regular quarterly cash dividends on its common stock and the appointment of a new Chief Financial Officer, including related compensation arrangements and transition agreements. The company has also filed 8‑Ks covering leadership changes in its U.S. Coffee segment and the appointment of a Chief Transformation and Supply Chain Officer.
For corporate transactions, Keurig Dr Pepper’s 8‑Ks outline the merger protocol for its recommended public cash offer to acquire all issued ordinary shares of JDE Peet’s N.V., including offer terms, conditions, post‑closing restructuring options and related irrevocable undertakings. Additional filings detail a bridge credit agreement intended to fund the acquisition and an investment agreement for Series A Convertible Perpetual Preferred Stock with investors affiliated with Apollo and KKR, including dividend terms, conversion mechanics, redemption rights and transfer restrictions.
Litigation and other matters are also addressed in KDP’s current reports, such as updates on multidistrict antitrust litigation related to Keurig Green Mountain single‑serve coffee. On Stock Titan, these filings are supplemented with AI‑powered summaries that explain the significance of each document, helping users quickly understand dividend actions, financing structures, executive changes, transaction steps and legal developments without reading every page of the original SEC text.
Keurig Dr Pepper Inc. Chief Legal Officer Anthony Shoemaker reported several equity award transactions. On March 4, 2026, he received two new restricted stock unit (RSU) grants covering 38,968 RSUs and 103,915 RSUs, each at no cash cost and each representing a right to one share of common stock upon vesting.
The 38,968 RSUs vest in four 25% installments on March 4, 2027, 2028, 2029, and 2030, while the 103,915 RSUs vest one third on each of March 4, 2027, 2028, and 2029. On March 5, 2026, 6,757 previously granted RSUs, originally awarded on March 5, 2025, converted into 6,757 shares of common stock, and 2,659 shares of common stock were withheld at $28.05 per share to cover taxes related to the vesting. After these transactions, Shoemaker directly owned 140,281 shares of common stock.
Keurig Dr Pepper Inc. Chief Supply Chain Officer Roger Frederick Johnson reported equity compensation transactions involving restricted stock units (RSUs) and common stock. On March 4, 2026, he received two new RSU awards of 103,915 units and 38,968 units, each converting into common stock on a one-for-one basis upon vesting.
According to the vesting terms, the 103,915 RSUs vest in four 25% installments on March 4, 2027, 2028, 2029, and 2030, while the 38,968 RSUs vest one-third on each of March 4, 2027, 2028, and 2029. On March 5, 2026, previously granted RSUs from March 5, 2025 vested and 6,757 RSUs were converted into 6,757 shares of common stock.
In connection with this vesting, 2,659 common shares were withheld at a price of $28.05 per share to cover applicable taxes, treated as a disposition for tax purposes under Rule 16b-3. After these transactions, Johnson directly owned 135,381 shares of common stock.
Keurig Dr Pepper Inc. CEO and President Timothy P. Cofer reported multiple equity award movements involving restricted stock units (RSUs) and common stock. On March 5, 30,969 RSUs converted into 30,969 shares of common stock at $0.00 per share, and 12,187 shares of common stock at $28.05 per share were withheld to cover taxes upon RSU vesting. Following these transactions, he directly held 458,852 shares of common stock and 92,905 RSUs. On March 4, he received new grants of 168,861 and 225,148 RSUs, which vest in specified installments between March 4, 2027 and March 2, 2031. An additional 400 common shares are reported as held indirectly by his children.
Keurig Dr Pepper Inc. director Robert James Gamgort reported several equity-compensation transactions. On March 5, 2026, 14,077 restricted stock units were exercised into an equal number of common shares at a stated price of $0.00 per share, and 5,540 common shares were withheld at $28.05 per share to cover tax obligations.
Following these transactions, his directly held common stock totaled 1,951,412 shares, and his remaining restricted stock units totaled 42,230. On March 4, 2026, he also received a grant of 10,392 restricted stock units that vest on March 4, 2031, and he reported indirect holdings of 102,142 and 1,000,000 common shares held by the 2024 Trust and 2025 Trust, respectively.
O'Toole Amie Thuener reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Amie Thuener O'Toole received a grant of 6,062 restricted stock units on March 4, 2026. The units were awarded at a price of $0.00 per unit and are held as a derivative security.
According to the terms, these restricted stock units are subject to vesting conditions and are scheduled to vest on March 4, 2031, subject to certain exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting, so the director will only receive the underlying shares if the vesting conditions are satisfied.
Newlands William A reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director William A. Newlands received a grant of 6,062 restricted stock units on March 4, 2026. The units were awarded at a price of $0.00 per unit and increased his directly owned restricted stock unit holdings to 6,062.
According to the terms, these restricted stock units are subject to vesting conditions and are scheduled to vest on March 4, 2031. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock when vesting occurs.
Sandler Debra A. reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Debra A. Sandler received a grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no cash cost per unit.
Subject to vesting conditions and exceptions, the restricted stock units are scheduled to vest on March 4, 2031, with each unit representing a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting.
Keurig Dr Pepper Inc. director Michael G. Van de Ven reported an equity compensation grant of 6,062 restricted stock units on March 4, 2026. These units were awarded at no exercise price and increase his directly held derivative position to 6,062 units.
According to the footnote, the restricted stock units vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock once vesting requirements are met, so this filing reflects a long‑term incentive award rather than an open‑market share purchase.
Boston Oray reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Boston Oray received a grant of 6,062 restricted stock units of company stock. According to the terms, these units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock when it vests.
Whiting Lawson E reported acquisition or exercise transactions in this Form 4 filing.
Keurig Dr Pepper Inc. director Lawson E. Whiting reported receiving a grant of 6,062 restricted stock units on March 4, 2026. The award was recorded at a price of $0.00 per unit, reflecting a compensatory grant rather than an open-market purchase.
According to the terms, these 6,062 restricted stock units are scheduled to vest on March 4, 2031, subject to certain vesting conditions and exceptions. Each unit represents a contingent right to receive one share of Keurig Dr Pepper common stock upon vesting, so no shares are issued until the vesting requirements are met.